STRATA Skin Sciences, Inc.
SSKN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $7 | $8 | $7 | $10 |
| % Growth | -9.6% | 12.5% | -28.9% | – |
| Cost of Goods Sold | $3 | $3 | $3 | $4 |
| Gross Profit | $4 | $4 | $4 | $6 |
| % Margin | 60.4% | 56.2% | 53.5% | 60.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $3 | $3 | $3 |
| SG&A Expenses | $6 | $6 | $6 | $6 |
| Sales & Mktg Exp. | $0 | $4 | $3 | $3 |
| Other Operating Expenses | $0 | $0 | $0 | $4 |
| Operating Expenses | $6 | $7 | $6 | $10 |
| Operating Income | -$2 | -$2 | -$2 | -$4 |
| % Margin | -26.8% | -29% | -29.6% | -44.1% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$2 | -$2 | -$2 | -$5 |
| Tax Expense | $0 | $0 | $0 | -$0 |
| Net Income | -$2 | -$2 | -$2 | -$4 |
| % Margin | -23.4% | -32.5% | -35.7% | -47% |
| EPS | -0.36 | -0.6 | -0.058 | -0.12 |
| % Growth | 40% | -929.2% | 51.4% | – |
| EPS Diluted | -0.36 | -0.6 | -0.058 | -0.12 |
| Weighted Avg Shares Out | 45 | 42 | 42 | 38 |
| Weighted Avg Shares Out Dil | 45 | 42 | 42 | 38 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$0 | -$1 | -$1 | -$3 |
| % Margin | -2.5% | -9% | -9.4% | -29.6% |